Loading…

Characterization of the peak at 2.06ppm in 31P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine?

High field MR scanners can resolve a metabolite resonating at 2.06ppm in the in vivo proton-decoupled liver 31P MR spectrum. Traditionally this peak has been assigned to phosphoenolpyruvate (PEP), the key metabolite for gluconeogenesis. However, recent evidence supported the assignment to biliary ph...

Full description

Saved in:
Bibliographic Details
Published in:NMR in biomedicine 2015-07, Vol.28 (7), p.898
Main Authors: Bierwagen, Alessandra, Begovatz, Paul, Nowotny, Peter, Markgraf, Daniel, Nowotny, Bettina, Koliaki, Chrysi, Giani, Guido, Kluppelholz, Birgit, Lundbom, Jesper, Roden, Michael
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 7
container_start_page 898
container_title NMR in biomedicine
container_volume 28
creator Bierwagen, Alessandra
Begovatz, Paul
Nowotny, Peter
Markgraf, Daniel
Nowotny, Bettina
Koliaki, Chrysi
Giani, Guido
Kluppelholz, Birgit
Lundbom, Jesper
Roden, Michael
description High field MR scanners can resolve a metabolite resonating at 2.06ppm in the in vivo proton-decoupled liver 31P MR spectrum. Traditionally this peak has been assigned to phosphoenolpyruvate (PEP), the key metabolite for gluconeogenesis. However, recent evidence supported the assignment to biliary phosphatidylcholine (PtdCh), which is produced in the liver and stored in the gall bladder. To elucidate the respective contributions of PtdCh and PEP to the in vivo resonance at 2.06ppm (PEP-PtdCh), we made phantom measurements that confirmed that both biliary PtdCh and PEP resonate approximately at 2ppm. The absolute quantification of PEP-PtdCh yielded concentrations ranging from 0.6 to 2.0mmol/l, with mean coefficients of variation of 4.8% for intraday and 7.2% for interday reproducibility in healthy volunteers. The T1 relaxation time of PEP-PtdCh was 0.97±0.30s in the liver and 0.44±0.11s in the gallbladder. Ingestion of a mixed meal decreased the concentration of PtdCh-PEP by approximately 12%. In the retrospective analysis, PEP-PtdCh was 68% higher in the liver of subjects with gallbladder infiltration of the volume of interest (VOI) compared with those without gallbladder infiltration. PEP-PtdCh was also significantly higher in the liver of cholecystectomy patients compared with volunteers without gallbladder infiltration, which suggests increased intrahepatic bile fluid as a compensation for gall bladder removal. These results show that liver PtdCh is the major component of the resonance at 2.06ppm and that careful VOI positioning is mandatory to avoid interference from the gallbladder. Copyright © 2015 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/nbm.3323
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1689862324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3720078131</sourcerecordid><originalsourceid>FETCH-proquest_journals_16898623243</originalsourceid><addsrcrecordid>eNqNjc9KxDAYxIMoWF3BR_jAc2v-1NJ48bAoHvfgfYnZb03WNl9M0oX6CD61FfYBPAwD85thGLsVvBGcy_vwPjZKSXXGKsG1rkWr5TmruH6QtWp7fsmucj5wzvtWyYr9rJ1JxhZM_tsUTwFoD8UhRDSfYArIhncxjuADKLGB0XwELN5CwkzBBIuQI9qSKFuK89_aTaMJMPgjpkeIjvIiDDTEOU1HUxAoneLlcDcP1tHgAz6t2MXeDBlvTn7N7l6e39avdUz0NWEu2wNNKSxoK7pe951UslX_a_0C8GhZ-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1689862324</pqid></control><display><type>article</type><title>Characterization of the peak at 2.06ppm in 31P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine?</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Bierwagen, Alessandra ; Begovatz, Paul ; Nowotny, Peter ; Markgraf, Daniel ; Nowotny, Bettina ; Koliaki, Chrysi ; Giani, Guido ; Kluppelholz, Birgit ; Lundbom, Jesper ; Roden, Michael</creator><creatorcontrib>Bierwagen, Alessandra ; Begovatz, Paul ; Nowotny, Peter ; Markgraf, Daniel ; Nowotny, Bettina ; Koliaki, Chrysi ; Giani, Guido ; Kluppelholz, Birgit ; Lundbom, Jesper ; Roden, Michael</creatorcontrib><description>High field MR scanners can resolve a metabolite resonating at 2.06ppm in the in vivo proton-decoupled liver 31P MR spectrum. Traditionally this peak has been assigned to phosphoenolpyruvate (PEP), the key metabolite for gluconeogenesis. However, recent evidence supported the assignment to biliary phosphatidylcholine (PtdCh), which is produced in the liver and stored in the gall bladder. To elucidate the respective contributions of PtdCh and PEP to the in vivo resonance at 2.06ppm (PEP-PtdCh), we made phantom measurements that confirmed that both biliary PtdCh and PEP resonate approximately at 2ppm. The absolute quantification of PEP-PtdCh yielded concentrations ranging from 0.6 to 2.0mmol/l, with mean coefficients of variation of 4.8% for intraday and 7.2% for interday reproducibility in healthy volunteers. The T1 relaxation time of PEP-PtdCh was 0.97±0.30s in the liver and 0.44±0.11s in the gallbladder. Ingestion of a mixed meal decreased the concentration of PtdCh-PEP by approximately 12%. In the retrospective analysis, PEP-PtdCh was 68% higher in the liver of subjects with gallbladder infiltration of the volume of interest (VOI) compared with those without gallbladder infiltration. PEP-PtdCh was also significantly higher in the liver of cholecystectomy patients compared with volunteers without gallbladder infiltration, which suggests increased intrahepatic bile fluid as a compensation for gall bladder removal. These results show that liver PtdCh is the major component of the resonance at 2.06ppm and that careful VOI positioning is mandatory to avoid interference from the gallbladder. Copyright © 2015 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0952-3480</identifier><identifier>EISSN: 1099-1492</identifier><identifier>DOI: 10.1002/nbm.3323</identifier><language>eng</language><publisher>Oxford: Wiley Subscription Services, Inc</publisher><ispartof>NMR in biomedicine, 2015-07, Vol.28 (7), p.898</ispartof><rights>Copyright © 2015 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bierwagen, Alessandra</creatorcontrib><creatorcontrib>Begovatz, Paul</creatorcontrib><creatorcontrib>Nowotny, Peter</creatorcontrib><creatorcontrib>Markgraf, Daniel</creatorcontrib><creatorcontrib>Nowotny, Bettina</creatorcontrib><creatorcontrib>Koliaki, Chrysi</creatorcontrib><creatorcontrib>Giani, Guido</creatorcontrib><creatorcontrib>Kluppelholz, Birgit</creatorcontrib><creatorcontrib>Lundbom, Jesper</creatorcontrib><creatorcontrib>Roden, Michael</creatorcontrib><title>Characterization of the peak at 2.06ppm in 31P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine?</title><title>NMR in biomedicine</title><description>High field MR scanners can resolve a metabolite resonating at 2.06ppm in the in vivo proton-decoupled liver 31P MR spectrum. Traditionally this peak has been assigned to phosphoenolpyruvate (PEP), the key metabolite for gluconeogenesis. However, recent evidence supported the assignment to biliary phosphatidylcholine (PtdCh), which is produced in the liver and stored in the gall bladder. To elucidate the respective contributions of PtdCh and PEP to the in vivo resonance at 2.06ppm (PEP-PtdCh), we made phantom measurements that confirmed that both biliary PtdCh and PEP resonate approximately at 2ppm. The absolute quantification of PEP-PtdCh yielded concentrations ranging from 0.6 to 2.0mmol/l, with mean coefficients of variation of 4.8% for intraday and 7.2% for interday reproducibility in healthy volunteers. The T1 relaxation time of PEP-PtdCh was 0.97±0.30s in the liver and 0.44±0.11s in the gallbladder. Ingestion of a mixed meal decreased the concentration of PtdCh-PEP by approximately 12%. In the retrospective analysis, PEP-PtdCh was 68% higher in the liver of subjects with gallbladder infiltration of the volume of interest (VOI) compared with those without gallbladder infiltration. PEP-PtdCh was also significantly higher in the liver of cholecystectomy patients compared with volunteers without gallbladder infiltration, which suggests increased intrahepatic bile fluid as a compensation for gall bladder removal. These results show that liver PtdCh is the major component of the resonance at 2.06ppm and that careful VOI positioning is mandatory to avoid interference from the gallbladder. Copyright © 2015 John Wiley &amp; Sons, Ltd.</description><issn>0952-3480</issn><issn>1099-1492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNjc9KxDAYxIMoWF3BR_jAc2v-1NJ48bAoHvfgfYnZb03WNl9M0oX6CD61FfYBPAwD85thGLsVvBGcy_vwPjZKSXXGKsG1rkWr5TmruH6QtWp7fsmucj5wzvtWyYr9rJ1JxhZM_tsUTwFoD8UhRDSfYArIhncxjuADKLGB0XwELN5CwkzBBIuQI9qSKFuK89_aTaMJMPgjpkeIjvIiDDTEOU1HUxAoneLlcDcP1tHgAz6t2MXeDBlvTn7N7l6e39avdUz0NWEu2wNNKSxoK7pe951UslX_a_0C8GhZ-A</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Bierwagen, Alessandra</creator><creator>Begovatz, Paul</creator><creator>Nowotny, Peter</creator><creator>Markgraf, Daniel</creator><creator>Nowotny, Bettina</creator><creator>Koliaki, Chrysi</creator><creator>Giani, Guido</creator><creator>Kluppelholz, Birgit</creator><creator>Lundbom, Jesper</creator><creator>Roden, Michael</creator><general>Wiley Subscription Services, Inc</general><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20150701</creationdate><title>Characterization of the peak at 2.06ppm in 31P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine?</title><author>Bierwagen, Alessandra ; Begovatz, Paul ; Nowotny, Peter ; Markgraf, Daniel ; Nowotny, Bettina ; Koliaki, Chrysi ; Giani, Guido ; Kluppelholz, Birgit ; Lundbom, Jesper ; Roden, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16898623243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bierwagen, Alessandra</creatorcontrib><creatorcontrib>Begovatz, Paul</creatorcontrib><creatorcontrib>Nowotny, Peter</creatorcontrib><creatorcontrib>Markgraf, Daniel</creatorcontrib><creatorcontrib>Nowotny, Bettina</creatorcontrib><creatorcontrib>Koliaki, Chrysi</creatorcontrib><creatorcontrib>Giani, Guido</creatorcontrib><creatorcontrib>Kluppelholz, Birgit</creatorcontrib><creatorcontrib>Lundbom, Jesper</creatorcontrib><creatorcontrib>Roden, Michael</creatorcontrib><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>NMR in biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bierwagen, Alessandra</au><au>Begovatz, Paul</au><au>Nowotny, Peter</au><au>Markgraf, Daniel</au><au>Nowotny, Bettina</au><au>Koliaki, Chrysi</au><au>Giani, Guido</au><au>Kluppelholz, Birgit</au><au>Lundbom, Jesper</au><au>Roden, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of the peak at 2.06ppm in 31P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine?</atitle><jtitle>NMR in biomedicine</jtitle><date>2015-07-01</date><risdate>2015</risdate><volume>28</volume><issue>7</issue><spage>898</spage><pages>898-</pages><issn>0952-3480</issn><eissn>1099-1492</eissn><abstract>High field MR scanners can resolve a metabolite resonating at 2.06ppm in the in vivo proton-decoupled liver 31P MR spectrum. Traditionally this peak has been assigned to phosphoenolpyruvate (PEP), the key metabolite for gluconeogenesis. However, recent evidence supported the assignment to biliary phosphatidylcholine (PtdCh), which is produced in the liver and stored in the gall bladder. To elucidate the respective contributions of PtdCh and PEP to the in vivo resonance at 2.06ppm (PEP-PtdCh), we made phantom measurements that confirmed that both biliary PtdCh and PEP resonate approximately at 2ppm. The absolute quantification of PEP-PtdCh yielded concentrations ranging from 0.6 to 2.0mmol/l, with mean coefficients of variation of 4.8% for intraday and 7.2% for interday reproducibility in healthy volunteers. The T1 relaxation time of PEP-PtdCh was 0.97±0.30s in the liver and 0.44±0.11s in the gallbladder. Ingestion of a mixed meal decreased the concentration of PtdCh-PEP by approximately 12%. In the retrospective analysis, PEP-PtdCh was 68% higher in the liver of subjects with gallbladder infiltration of the volume of interest (VOI) compared with those without gallbladder infiltration. PEP-PtdCh was also significantly higher in the liver of cholecystectomy patients compared with volunteers without gallbladder infiltration, which suggests increased intrahepatic bile fluid as a compensation for gall bladder removal. These results show that liver PtdCh is the major component of the resonance at 2.06ppm and that careful VOI positioning is mandatory to avoid interference from the gallbladder. Copyright © 2015 John Wiley &amp; Sons, Ltd.</abstract><cop>Oxford</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/nbm.3323</doi></addata></record>
fulltext fulltext
identifier ISSN: 0952-3480
ispartof NMR in biomedicine, 2015-07, Vol.28 (7), p.898
issn 0952-3480
1099-1492
language eng
recordid cdi_proquest_journals_1689862324
source Wiley-Blackwell Read & Publish Collection
title Characterization of the peak at 2.06ppm in 31P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A54%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20the%20peak%20at%202.06ppm%20in%2031P%20magnetic%20resonance%20spectroscopy%20of%20human%20liver:%20phosphoenolpyruvate%20or%20phosphatidylcholine?&rft.jtitle=NMR%20in%20biomedicine&rft.au=Bierwagen,%20Alessandra&rft.date=2015-07-01&rft.volume=28&rft.issue=7&rft.spage=898&rft.pages=898-&rft.issn=0952-3480&rft.eissn=1099-1492&rft_id=info:doi/10.1002/nbm.3323&rft_dat=%3Cproquest%3E3720078131%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_16898623243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1689862324&rft_id=info:pmid/&rfr_iscdi=true